"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
| Descriptor ID |
D011379
|
| MeSH Number(s) |
E01.789
|
| Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 22 | 22 |
| 1997 | 0 | 30 | 30 |
| 1998 | 0 | 34 | 34 |
| 1999 | 0 | 29 | 29 |
| 2000 | 0 | 46 | 46 |
| 2001 | 0 | 37 | 37 |
| 2002 | 0 | 38 | 38 |
| 2003 | 0 | 57 | 57 |
| 2004 | 0 | 57 | 57 |
| 2005 | 0 | 60 | 60 |
| 2006 | 0 | 76 | 76 |
| 2007 | 0 | 89 | 89 |
| 2008 | 0 | 87 | 87 |
| 2009 | 0 | 99 | 99 |
| 2010 | 0 | 110 | 110 |
| 2011 | 0 | 136 | 136 |
| 2012 | 0 | 116 | 116 |
| 2013 | 2 | 159 | 161 |
| 2014 | 2 | 181 | 183 |
| 2015 | 0 | 183 | 183 |
| 2016 | 6 | 164 | 170 |
| 2017 | 3 | 208 | 211 |
| 2018 | 1 | 239 | 240 |
| 2019 | 1 | 257 | 258 |
| 2020 | 0 | 232 | 232 |
| 2021 | 1 | 154 | 155 |
| 2022 | 0 | 77 | 77 |
| 2023 | 0 | 95 | 95 |
| 2024 | 0 | 147 | 147 |
| 2025 | 0 | 103 | 103 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma. Blood Adv. 2026 Jan 13; 10(1):217-227.
-
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group. Clin Cancer Res. 2026 Jan 06; 32(1):127-134.
-
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis. J Neurol Neurosurg Psychiatry. 2025 Oct 15; 96(11):1046-1052.
-
Advances and updates in pediatric anaplastic large cell lymphoma. Blood Adv. 2025 Oct 14; 9(19):4870-4880.
-
Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy. Cancer Res. 2025 Oct 01; 85(19):3737-3751.
-
Functional outcomes in pediatric patients on renal replacement therapy in a worldwide registry. Nephrol Dial Transplant. 2025 Sep 29; 40(10):1919-1930.
-
Visit-to-visit lipid variability, coronary artery calcification, inflammation, and mortality in the Multi-Ethnic Study of Atherosclerosis. Eur J Prev Cardiol. 2025 Sep 22; 32(13):1235-1244.
-
Clinical and Prognostic Utility of the Essential Frailty Toolset in Older Patients With Heart Failure. J Am Geriatr Soc. 2025 Nov; 73(11):3455-3463.
-
The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myeloma. Leukemia. 2025 Dec; 39(12):3004-3014.
-
Perinatal Prognostic Factors of Recurrence or Functional Sequelae in Neonatal Sacrococcygeal Teratoma, and Implications for Prenatal Counselling: A Multicenter Retrospective Study. J Pediatr Surg. 2025 Dec; 60(12):162687.